NEOG

Neogen Corporation NASDAQ

Healthcare ·Medical - Diagnostics & Research ·US · neogen.com

$9.09

Mkt Cap $2.0B

52w Low $4.53 66.1% of range 52w High $11.43

50d MA $9.70 200d MA $7.48

P/E (TTM) -1.9x

EV/EBITDA -2.2x

P/B 1.0x

Debt/Equity 0.4x

ROE -52.2%

P/FCF -27.4x

RSI (14) —

ATR (14) —

Beta 1.97

50d MA $9.70

200d MA $7.48

Avg Volume 2.8M

About

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organism…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Apr 9, 2026	AMC	0.04	0.09	+125.0%	10.04	-0.8%	-6.2%	-9.0%	-4.3%	-6.2%	-8.0%	—	—
Jan 8, 2026	AMC	0.07	0.10	+42.9%	9.71	+2.8%	-0.9%	-3.5%	-5.4%	-3.3%	-2.6%	+9.3%	—
Oct 9, 2025	AMC	-0.07	0.04	+154.1%	6.78	+1.5%	-10.9%	-12.2%	-12.8%	-12.2%	-12.5%	-6.2%	—
Jul 29, 2025	AMC	0.08	0.05	-37.5%	4.83	-0.4%	-2.7%	-3.7%	-3.5%	-3.1%	-3.1%	+19.0%	—
Apr 9, 2025	AMC	0.13	0.10	-23.1%	5.02	+2.4%	+12.2%	+11.2%	+7.6%	-1.4%	-8.4%	+18.9%	—
Jan 10, 2025	AMC	0.09	0.11	+22.2%	12.36	-0.6%	+2.3%	-2.9%	-8.1%	-6.1%	-6.5%	-15.7%	—
Oct 10, 2024	AMC	0.09	0.07	-17.6%	13.79	+0.1%	+4.6%	+1.7%	+6.8%	+5.9%	+4.9%	+18.9%	—
Jul 30, 2024	AMC	0.12	0.10	-16.7%	17.58	-0.5%	-3.1%	-3.3%	-6.8%	-8.1%	-4.7%	-2.6%	—
Apr 9, 2024	AMC	0.14	0.12	-14.3%	13.04	-1.7%	-4.1%	-0.3%	-5.1%	-7.9%	-6.7%	-4.7%	—
Jan 9, 2024	AMC	0.15	0.11	-26.7%	18.18	-0.4%	+3.1%	-0.1%	+0.0%	-1.0%	-7.2%	-10.6%	—
Oct 10, 2023	AMC	0.14	0.11	-21.4%	16.06	-0.4%	-6.8%	-6.8%	-3.7%	-4.2%	-5.7%	-6.0%	—
Jul 27, 2023	AMC	0.10	0.14	+40.0%	22.25	+1.3%	+3.8%	+4.2%	+1.5%	+1.6%	+0.8%	+3.0%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Jan 12	Piper Sandler	Maintains	Neutral → Neutral	—	$9.62	$9.62	+0.0%	-2.6%	-4.5%	-2.4%	-1.7%	-3.8%
Jan 9	Guggenheim	Maintains	Buy → Buy	—	$9.71	$9.98	+2.8%	-0.9%	-3.5%	-5.4%	-3.3%	-2.6%
Dec 10	CJS Securities	Upgrade	Market Perform → Market Outperform	—	$6.40	$6.39	-0.2%	+9.1%	+10.0%	+7.2%	+7.0%	+10.0%
Oct 16	Piper Sandler	Maintains	Neutral → Neutral	—	$5.95	$6.08	+2.2%	-0.3%	-1.2%	-1.0%	-0.8%	+3.2%
Jul 29	William Blair	Downgrade	Outperform → Market Perform	—	$5.42	$4.96	-8.5%	-10.9%	-13.3%	-14.2%	-14.0%	-13.7%
Jun 30	Guggenheim	Maintains	Buy → Buy	—	$4.73	$4.69	-0.8%	+1.1%	+7.4%	+10.6%	+12.7%	+5.3%
Apr 22	Piper Sandler	Maintains	Neutral → Neutral	—	$4.69	$4.65	-0.9%	+1.3%	+4.9%	+10.9%	+10.0%	+9.6%
Apr 14	Piper Sandler	Maintains	Neutral → Neutral	—	$5.58	$5.68	+1.8%	-3.2%	-11.3%	-17.6%	-21.3%	-15.9%
Apr 10	Guggenheim	Maintains	Buy → Buy	—	$5.02	$5.14	+2.4%	+12.2%	+11.2%	+7.6%	-1.4%	-8.4%
Jan 21	Piper Sandler	Maintains	Neutral → Neutral	—	$11.56	$11.47	-0.8%	+1.6%	+3.4%	+1.6%	-0.8%	+2.3%
Aug 6	Piper Sandler	Maintains	Neutral → Neutral	—	$16.15	$16.11	-0.2%	+3.7%	+1.4%	+5.2%	+4.0%	+1.7%
Apr 15	Piper Sandler	Maintains	Neutral → Neutral	—	$12.38	$12.26	-1.0%	-3.0%	-1.8%	-1.9%	-3.6%	-6.2%
Jan 18	Piper Sandler	Maintains	Neutral → Neutral	—	$16.88	$17.02	+0.8%	+0.7%	+0.7%	-0.5%	-0.5%	-3.0%
Oct 16	Piper Sandler	Maintains	Neutral → Neutral	—	$15.47	$15.45	-0.1%	-0.5%	-2.1%	-0.8%	-3.1%	-2.7%
Aug 14	Wells Fargo	Maintains	Overweight → Overweight	—	$22.50	$22.75	+1.1%	+4.9%	+6.0%	+2.6%	+0.2%	+0.0%
Dec 15	Piper Sandler	Maintains	Neutral → Neutral	—	$15.35	$15.16	-1.2%	-1.4%	-3.1%	-4.6%	-5.1%	-2.7%
Nov 22	William Blair	Upgrade	Market Perform → Outperform	—	$15.45	$16.01	+3.6%	+2.8%	+4.9%	+5.3%	-1.4%	+0.3%
Oct 10	Piper Sandler	Maintains	Neutral → Neutral	—	$12.68	$12.75	+0.6%	-4.5%	-7.9%	-3.8%	-4.3%	-10.6%
Aug 30	Piper Sandler	Maintains	Neutral → Neutral	—	$21.54	$21.24	-1.4%	-1.7%	-3.0%	-11.8%	-16.3%	-21.3%
Aug 1	Piper Sandler	Maintains	Neutral → Neutral	—	$23.13	$23.08	-0.2%	-2.4%	-4.4%	-4.1%	-6.8%	-7.4%
Jul 12	Piper Sandler	Maintains	Neutral → Neutral	—	$22.88	$22.74	-0.6%	-1.0%	-4.5%	-5.6%	-1.7%	-5.2%
Mar 19	Craig-Hallum	Upgrade	Hold → Buy	—	$31.53	$32.22	+2.2%	+1.5%	+1.3%	+1.5%	-5.4%	-4.0%
Mar 27	Stephens & Co.	Maintains	Equal Weight → Equal Weight	—	$33.08	$33.01	-0.2%	-0.8%	+0.7%	+1.2%	-1.0%	+1.1%
Jul 14	CL King	Maintains	Neutral → Neutral	—	$25.53	$25.43	-0.4%	+0.3%	+0.5%	-5.1%	-1.7%	-0.8%
Dec 22	Craig-Hallum	Downgrade	Buy → Hold	—	$22.60	$21.57	-4.6%	-5.7%	-3.6%	-3.3%	-3.6%	-3.5%
Mar 17	Stephens & Co.	Downgrade	Overweight → Equal Weight	—	$19.12	$18.76	-1.9%	-3.3%	-4.1%	-2.1%	-1.3%	-0.4%
Aug 11	Cowen & Co.	Maintains	Market Perform → Hold	—	$16.59	$16.58	-0.1%	+0.6%	+1.4%	+1.6%	+1.9%	+1.7%
Aug 15	Janney Capital	Maintains	Neutral → Neutral	—	$14.25	$14.03	-1.5%	-1.2%	-4.1%	-4.8%	-5.8%	-5.1%
Jul 24	Wellington Shields	Downgrade	Hold → Sell	—	$14.57	$14.25	-2.2%	-3.5%	-1.1%	-1.4%	-2.8%	-2.9%

Recent Filings

8-K · 7.01 ! Medium

Neogen Corp -- 8-K 7.01: Regulation FD Disclosure

Neogen is advancing manufacturing validation of its Petrifilm product line ahead of facility tours, signaling progress toward increased production capacity and commercial expansion.

Apr 20

8-K

Unknown — 8-K Filing

NEOG's Food Safety segment momentum suggests a successful turnaround is underway, potentially justifying higher valuations if stabilization continues in coming quarters.

Apr 9

8-K · 5.02 !!! Very High

Unknown — 8-K 5.02: Executive Change

An executive appointment to external board leadership suggests confidence in management quality and may signal stability, though investors should monitor whether divided attention impacts operational focus at the primary company.

Apr 1

8-K · 5.02 !!! Very High

Unknown — 8-K 5.02: Executive Change

I cannot provide meaningful analysis because the filing excerpt contains only formatting code and incomplete header information without disclosing which executive changed roles or their significance to NEOG's operations and strategy.

Mar 30

Data updated apr 26, 2026 2:40pm · Source: massive.com